Skip Navigation

Gender Differences in Statin Prescription Rate Among Patients Living With HIV and Hepatitis C Virus

  1. Chris T. Longenecker1
  1. 1Harrington Heart and Vascular Institute, University Hospitals Case Medical Center and School of Medicine
  2. 2Division of Infectious Diseases, Rainbow Babies and Children's Hospital and School of Medicine, Case Western Reserve University, Cleveland, Ohio
  1. Correspondence: C. T. Longenecker, Case Western Reserve University School of Medicine, 11100 Euclid Ave, Cleveland, OH 44106 (cxl473{at}case.edu).

To the Editor—We read with interest the recent article by Clement et al [1]. In this analysis of the veteran clinical case registry, statins were underutilized for primary or secondary prevention in patients living with human immunodeficiency virus (HIV), hepatitis C virus (HCV), and HIV/HCV coinfection. We wondered whether similar patterns of underutilization would be seen in a national clinical registry representing approximately 8% of the US population. Additionally, because the veteran clinical case registry analysis excluded women, we wished to explore gender differences in statin utilization in these cohorts.

We utilized Explorys, a large registry of US patients …

| Table of Contents

Published on behalf of

cid cover HIV Medicine Association Logo

Society Members: For your free access to this journal, log in via the IDSA members area.

Impact Factor: 8.886

5-Yr impact factor: 9.206

For Reviewers

Looking for your next opportunity?

Looking for jobs...

For the Media